These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4603996)

  • 1. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
    Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
    Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of platelet deaggregating substances on renal allograft rejection in sensitized dogs.
    Claes G
    Acta Chir Scand; 1973; 139(2):127-30. PubMed ID: 4577927
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet alterations during accelerated rejection of canine renal allografts.
    Claes G; Ljungqvist U
    Acta Chir Scand; 1973; 139(2):123-6. PubMed ID: 4577926
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts.
    Mathew TH; Clyne DH; Nanra RS; Kincaid-Smith P; Saker BM; Morris PJ; Marshall VC
    Lancet; 1974 Jun; 1(7870):1307-10. PubMed ID: 4134294
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of dipyridamole on the results of allogenic kidney transplantation].
    Schulze R; Langkopf B; Sziegoleit W
    Z Urol Nephrol; 1990 May; 83(5):255-9. PubMed ID: 2203215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
    Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
    Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
    George CR; Slichter SJ; Quadracci LJ; Kenny GM; Dennis MB; Striker GE; Harker LA
    Transplantation; 1975 Sep; 20(3):237-40. PubMed ID: 1099729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study.
    Sharma HM; Moore S; Merrick HW; Smith MR
    Am J Pathol; 1972 Mar; 66(3):445-60. PubMed ID: 4551295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo method to detect platelet trapping.
    Claes G; Bergentz SE; Roos B; Rosengren B
    Eur Surg Res; 1970; 2(1):48-54. PubMed ID: 4950492
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiography and isotope renography in acute rejection of renal transplant.
    Laasonen L; Kock B
    Scand J Urol Nephrol; 1978; 12(1):79-82. PubMed ID: 345435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of high dose prednisolone from plasma after renal transplantation.
    Park HS; Greene JA; Bacon GE
    Clin Nephrol; 1974; 2(1):18-23. PubMed ID: 4595979
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of transplant renal artery stenosis.
    Kauffman HM; Sampson D; Fox PS; Doyle TJ; Maddison FE
    Surgery; 1977 Feb; 81(2):161-7. PubMed ID: 319550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine as treatment for corticosteroid-resistant rejection episodes in renal transplantation.
    Garcia VD; Goldani JC; Garcia CD; Cantisani GP; Losekann A; Messias A; Mattos DB; Vitola SP; Bianchini JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1643-5. PubMed ID: 2652537
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial of dipyridamole as an immunomodulator in renal allograft recipients.
    Niyamathullah MM; Hariharan S; Jacob CK; Pandey AP; Gopalakrishnan G; Date A; Shastry JC; Kirubakaran MG
    Transplantation; 1989 Jun; 47(6):1071-2. PubMed ID: 2660346
    [No Abstract]   [Full Text] [Related]  

  • 15. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiographic diagnosis of the rejection reaction of renal grafts].
    Kleĭza VI; Daĭnis BE; Kosinskas EB
    Vestn Rentgenol Radiol; 1979; (2):39-44. PubMed ID: 375565
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on platelets and fibrin during rejection of canine renal allografts.
    Claes G
    Scand J Urol Nephrol; 1972; 10():1-24. PubMed ID: 4562640
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between percutaneous renal biopsy and the indium-111-labeled platelet scan in diagnosing acute renal allograft rejection.
    Lederer ED; Gillum DM; Jhingran S; Matula C; Truong L
    Transplantation; 1992 Apr; 53(4):945-7. PubMed ID: 1566364
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of anti-thrombotic therapy in renal disease.
    Kincaid-Smith P
    Scand J Haematol Suppl; 1979; 34():83-9. PubMed ID: 384508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.